Effectiveness and tolerability of an emollient ‘plus’ formulation in patients with xerosis or atopic dermatitis: results of a real-world observational study conducted in the United Kingdom

F. Aslanian, C. Kasparis, D. Kerob, L. Gayford, J. Whyte, S. Burgess, H. Alkaissi

INTRODUCTION & OBJECTIVES

Emollients are recommended as basic skin care in patients with any severity of atopic dermatitis (AD).¹

Emollient ‘plus’ are emollients that contain active ingredients that can improve eczema lesions and influence the skin microbiome of patients with AD.²

The aim of this study was to assess the impact of an Emollient ‘plus’ on symptom management and health-related quality of life (HRQoL) in patients with xerosis, including those with AD.